SCOPUS BIOPHARMA INC (SCPS)
US8091711015 - Common Stock
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -16.40M | -26.95M | -10.86M | -2.69M | -690.00K | |||
| Depreciation Amortization | 1.85K | 1.50K | 0.00 | 0.00 | N/A | |||
| Change In Working Capital | 3.98M | 2.84M | 1.15M | 360.00K | -130.00K | |||
| Interest Paid | N/A | 25.04K | N/A | N/A | N/A | |||
| Other non cash items | 561.38K | 12.69M | 7.19M | 210.00K | 70.00K | |||
| OPERATING CASH FLOW | -11.85M | -11.42M | -2.53M | -2.12M | -750.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.55K | -2.00K | 0.00 | 0.00 | N/A | |||
| INVESTING CASH FLOW | -1.55K | -2.00K | 0.00 | 0.00 | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -104.51K | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 9.75M | 20.10M | 5.46M | 2.64M | 560.00K | |||
| Other Financing Activity | -1.27M | -2.44M | -1.11M | -450.00K | 40.00K | |||
| FINANCING CASH FLOW | 8.48M | 17.56M | 4.35M | 2.18M | 600.00K | |||
| Exchange Rate Effect | 53.48K | -19.26K | -30.00K | -20.00K | -10.00K | |||
| CHANGE IN CASH | -3.32M | 6.11M | 1.79M | 40.00K | -160.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -11.85M | -11.42M | -2.53M | -2.12M | -750.00K | |||
| Capital Expenditure | -1.55K | -2.00K | 0.00 | 0.00 | N/A | |||
| FREE CASH FLOW | -11.85M | -11.43M | -2.53M | -2.12M | -750.00K | |||
All data in USD